IL326647A - Lipid nanoparticle with nucleic acid cargo and ionizable lipid - Google Patents
Lipid nanoparticle with nucleic acid cargo and ionizable lipidInfo
- Publication number
- IL326647A IL326647A IL326647A IL32664726A IL326647A IL 326647 A IL326647 A IL 326647A IL 326647 A IL326647 A IL 326647A IL 32664726 A IL32664726 A IL 32664726A IL 326647 A IL326647 A IL 326647A
- Authority
- IL
- Israel
- Prior art keywords
- lipid
- nucleic acid
- acid cargo
- ionizable
- nanoparticle
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT506942023 | 2023-09-01 | ||
| PCT/EP2024/074369 WO2025046121A1 (en) | 2023-09-01 | 2024-08-30 | Lipid nanoparticle with nucleic acid cargo and ionizable lipid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326647A true IL326647A (en) | 2026-04-01 |
Family
ID=87886730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326647A IL326647A (en) | 2023-09-01 | 2024-08-30 | Lipid nanoparticle with nucleic acid cargo and ionizable lipid |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN121752256A (en) |
| AU (1) | AU2024330157A1 (en) |
| IL (1) | IL326647A (en) |
| WO (1) | WO2025046121A1 (en) |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19607722A1 (en) | 1996-02-29 | 1997-09-04 | Freisleben H J Dr | Tetraether lipids and liposomes containing them and their use |
| US20030073640A1 (en) | 1997-07-23 | 2003-04-17 | Ribozyme Pharmaceuticals, Inc. | Novel compositions for the delivery of negatively charged molecules |
| DE19736592C2 (en) | 1997-08-22 | 2002-01-24 | Bernina Biosystems Gmbh | Tetraether lipid derivative, one or more tetraether lipid derivatives containing liposome or lipid agglomerate and pharmaceutical composition |
| US6316260B1 (en) | 1997-08-22 | 2001-11-13 | Bernina Biosystems Gmbh | Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraether lipid derivatives, and use thereof |
| DE10065561A1 (en) | 2000-12-28 | 2002-07-11 | Bernina Biosystems Gmbh | Liposomes and lipid agglomerates containing tetraether lipid derivatives and tetraether lipid derivatives and their use |
| DE10109897A1 (en) | 2001-02-21 | 2002-11-07 | Novosom Ag | Optional cationic liposomes and their use |
| WO2003064360A1 (en) | 2002-02-01 | 2003-08-07 | Bernina Biosystems Gmbh | Synthetic tetraethers and synthesis strategies therefor |
| DE10249401A1 (en) | 2002-10-23 | 2004-05-13 | Bernina Biosystems Gmbh | Liposome forming composition |
| JP5042863B2 (en) | 2005-02-14 | 2012-10-03 | サーナ・セラピューティクス・インコーポレイテッド | Lipid nanoparticle-based compositions and methods for delivering biologically active molecules |
| US7404969B2 (en) | 2005-02-14 | 2008-07-29 | Sirna Therapeutics, Inc. | Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules |
| AT502713B1 (en) | 2005-10-19 | 2008-08-15 | Univ Wien Bodenkultur | METHOD FOR PRODUCING LIPID MEMBRANES |
| CA2647060C (en) | 2006-03-30 | 2014-10-21 | National Research Council Of Canada | Synthetic archaeal glycolipid adjuvants |
| US20140178462A1 (en) | 2006-10-13 | 2014-06-26 | Marina Biotech, Inc. | Amphoteric liposomes comprising neutral lipids |
| TW200833709A (en) | 2006-12-15 | 2008-08-16 | Ca Nat Research Council | Archaeal polar lipid aggregates for administration to animals |
| US20100015218A1 (en) | 2007-02-16 | 2010-01-21 | Vasant Jadhav | Compositions and methods for potentiated activity of biologically active molecules |
| GB2463801B (en) | 2007-03-20 | 2011-07-13 | Univ Plymouth | Isoprenoid compounds, their isolation and use |
| ATE502114T1 (en) | 2007-06-21 | 2011-04-15 | Univ Muenchen Tech | BIOLOGICALLY ACTIVE PROTEINS WITH INCREASED IN-VIVO AND/OR IN-VITRO STABILITY |
| AU2009238175C1 (en) | 2008-04-15 | 2023-11-30 | Arbutus Biopharma Corporation | Novel lipid formulations for nucleic acid delivery |
| US20110224447A1 (en) | 2008-08-18 | 2011-09-15 | Bowman Keith A | Novel Lipid Nanoparticles and Novel Components for Delivery of Nucleic Acids |
| US9957534B2 (en) | 2008-11-06 | 2018-05-01 | Kiverdi, Inc. | Engineered CO2-fixing chemotrophic microorganisms producing carbon-based products and methods of using the same |
| WO2010080724A1 (en) | 2009-01-12 | 2010-07-15 | Merck Sharp & Dohme Corp. | Novel lipid nanoparticles and novel components for delivery of nucleic acids |
| ES2613498T3 (en) | 2009-07-01 | 2017-05-24 | Protiva Biotherapeutics Inc. | New lipid formulations for the delivery of therapeutic agents to solid tumors |
| US8569256B2 (en) | 2009-07-01 | 2013-10-29 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods for the delivery of therapeutic agents |
| EP2467357B1 (en) | 2009-08-20 | 2016-03-30 | Sirna Therapeutics, Inc. | Novel cationic lipids with various head groups for oligonucleotide delivery |
| AU2010290131C1 (en) | 2009-08-24 | 2015-12-03 | Amunix Operating Inc. | Coagulation factor VII compositions and methods of making and using same |
| US20120253032A1 (en) | 2009-10-08 | 2012-10-04 | Merck Sharp & Dohme Corporation | Novel cationic lipids with short lipid chains for oligonucleotide delivery |
| US20130116419A1 (en) | 2010-01-22 | 2013-05-09 | Daniel Zewge | Post-synthetic chemical modification of rna at the 2'-position of the ribose ring via "click" chemistry |
| US9254327B2 (en) | 2010-05-10 | 2016-02-09 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for delivery of active agents |
| US8802863B2 (en) | 2010-05-24 | 2014-08-12 | Sirna Therapeutics, Inc. | Amino alcohol cationic lipids for oligonucleotide delivery |
| US8748667B2 (en) | 2010-06-04 | 2014-06-10 | Sirna Therapeutics, Inc. | Low molecular weight cationic lipids for oligonucleotide delivery |
| WO2012000104A1 (en) | 2010-06-30 | 2012-01-05 | Protiva Biotherapeutics, Inc. | Non-liposomal systems for nucleic acid delivery |
| US8466122B2 (en) | 2010-09-17 | 2013-06-18 | Protiva Biotherapeutics, Inc. | Trialkyl cationic lipids and methods of use thereof |
| ES2888231T3 (en) | 2010-09-20 | 2022-01-03 | Sirna Therapeutics Inc | Low molecular weight cationic lipids for oligonucleotide delivery |
| EP2621480B1 (en) | 2010-09-30 | 2018-08-15 | Sirna Therapeutics, Inc. | Low molecular weight cationic lipids for oligonucleotide delivery |
| JP2013545727A (en) | 2010-10-21 | 2013-12-26 | メルク・シャープ・アンド・ドーム・コーポレーション | Novel low molecular weight cationic lipids for oligonucleotide delivery |
| EP2635265B1 (en) | 2010-11-05 | 2018-04-04 | Sirna Therapeutics, Inc. | Novel low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery |
| US9126966B2 (en) | 2011-08-31 | 2015-09-08 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods of use thereof |
| EP2788006B1 (en) | 2011-12-07 | 2026-01-07 | Alnylam Pharmaceuticals, Inc. | Biodegradable lipids for the delivery of active agents |
| US20140308304A1 (en) | 2011-12-07 | 2014-10-16 | Alnylam Pharmaceuticals, Inc. | Lipids for the delivery of active agents |
| CN104114572A (en) | 2011-12-16 | 2014-10-22 | 现代治疗公司 | Modified nucleosides, nucleotides and nucleic acid compositions |
| EP2968147A4 (en) | 2013-03-15 | 2017-02-22 | The Penn State Research Foundation | Acid stable liposomal compositions |
| EP4286012A3 (en) | 2015-09-17 | 2024-05-29 | ModernaTX, Inc. | Compounds and compositions for intracellular delivery of therapeutic agents |
| EP3158992A1 (en) | 2015-10-21 | 2017-04-26 | Universität Heidelberg | Liposomes containing cell penetrating peptides and tetraetherlipids for the oral delivery of macromolecules |
| HRP20220652T1 (en) | 2015-12-10 | 2022-06-24 | Modernatx, Inc. | Compositions and methods for delivery of therapeutic agents |
| HUE057877T2 (en) | 2015-12-22 | 2022-06-28 | Modernatx Inc | Compounds and preparations for the intracellular delivery of therapeutic agents |
| FR3052361B1 (en) | 2016-06-09 | 2019-08-23 | Centre National De La Recherche Scientifique | DIETHERS OF ARCHAEA SYNTHETIC LIPIDS |
| WO2018126084A1 (en) | 2016-12-30 | 2018-07-05 | Phaserx, Inc. | Branched peg molecules and related compositions and methods |
| CA3080592A1 (en) | 2017-10-31 | 2019-05-09 | Modernatx, Inc. | Lipid nanoparticles for delivering modified rna encoding a vegf-a polypeptide |
| MA53650A (en) | 2018-09-19 | 2021-07-28 | Modernatx Inc | PEG LIPIDS AND THEIR USES |
| KR20210120988A (en) | 2018-11-02 | 2021-10-07 | 제네반트 사이언시즈 게엠베하 | treatment method |
| EP3708151A1 (en) | 2019-03-15 | 2020-09-16 | Technische Universität Wien | Method for producing a composition comprising archaeal lipids from a sulfolobus cell culture |
| AU2020262437A1 (en) | 2019-04-26 | 2021-12-23 | Genevant Sciences Gmbh | Lipid nanoparticles |
| KR20220121246A (en) | 2019-12-20 | 2022-08-31 | 큐어백 아게 | Novel Lipid Nanoparticles for Nucleic Acid Delivery |
-
2024
- 2024-08-30 IL IL326647A patent/IL326647A/en unknown
- 2024-08-30 CN CN202480056093.1A patent/CN121752256A/en active Pending
- 2024-08-30 AU AU2024330157A patent/AU2024330157A1/en active Pending
- 2024-08-30 WO PCT/EP2024/074369 patent/WO2025046121A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025046121A1 (en) | 2025-03-06 |
| AU2024330157A1 (en) | 2026-04-02 |
| CN121752256A (en) | 2026-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL319752A (en) | Lipid nanoparticle with nucleic acid cargo | |
| EP3987031A4 (en) | Nucleic acid construct comprising 5' utr stem-loop for in vitro and in vivo gene expression | |
| IL307526A (en) | Ionizable lipids and compositions for nucleic acid delivery | |
| GB2596224B (en) | Lipid nanoparticle compositions for delivery of mRNA and long nucleic acids | |
| PL4011806T3 (en) | Container handling vehicle with first and second sections and assembly of motors in second section for driving at least one wheel of each of the sets of wheels | |
| SG11202010196TA (en) | Land and Aerial Transportation Vehicle and Powertrain thereof | |
| IL289258A (en) | Micellar nanoparticles and uses thereof | |
| EP2553626A4 (en) | Segmentation of textual lines in an image that include western characters and hieroglyphic characters | |
| IL317109A (en) | Lipid nanoparticles for delivery of nucleic acids and methods of use thereof | |
| EP3972571A4 (en) | Methods using photothermal nanoparticles in rapid nucleic acid amplification and photothermal nanoparticles | |
| PL3762328T3 (en) | Cargo handling vehicle for navigation in narrow aisles and method therefore | |
| IL317136A (en) | Cell delivery vehicle and methods of using the same | |
| EP4310071A4 (en) | Lipid compound and use thereof in delivery of nucleic acid | |
| EP4163204A4 (en) | Flying body and method for transporting load using same | |
| IL326647A (en) | Lipid nanoparticle with nucleic acid cargo and ionizable lipid | |
| IL320587A (en) | Ionizable lipids and lipid nanoparticle compositions for the delivery of nucleic acids | |
| PH12017501391A1 (en) | Anchoring system for building constructions | |
| EP4402274A4 (en) | Stabilized lipid nanoparticle mrna compositions and uses thereof | |
| CA3301802A1 (en) | Lipid nanoparticle with nucleic acid cargo and ionizable lipid | |
| Li et al. | Injective choosability of planar graphs of girth five and six | |
| EP3906311A4 (en) | Car t cell methods and constructs | |
| EP4271363A4 (en) | Micellar nanoparticles and uses thereof | |
| WO2024049979A3 (en) | Novel ionizable lipids and lipid nanoparticles and methods of using the same | |
| IL307733A (en) | Nucleic acid enrichment and detection | |
| HU5003U (en) | System of placing and movement of inserted cells in goods transportation packages |